Business Quote by Dilip Shanghvi
“Sun Pharma's relationship with AML is on an arm's-length basis. As investors have expressed concerns regarding this arrangement, we are in the process of evaluating various options for undertaking domestic formulation business.”
About This Quote
Source Statement: Investor Relations Release, Sun Pharma, 2024
The company maintains a distant, transactional link with AML, prompting investor concern and a strategic review of domestic formulation options.
In simple terms: Sun Pharma keeps AML at arm’s length, now reviewing formulation plans.
Reassess partnership strategy.
Themes
Mood
Type
When to use this quote
- shareholder meetings
- board deliberations
- market analysis
- regulatory review
Key Concepts
Questions to Reflect On
- How can Sun Pharma balance independence with collaboration?
- What risks does a distant partnership pose?
Potential loss of synergy if partnership is too distant.